Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J.P. Morgan 2024: Optimism With An Undercurrent Of Tension

Jan 11 2024

• By Jessica Merrill

J.P. Morgan 2024 — • Source: Shutterstock

Related Content

Deal Watch: Coherus Terminates Immuno-Oncology Alliance With Junshi

Jan 10 2024

GSK Takes A Deep Breath And Drops $1bn On Aiolos

Jan 09 2024

Merck & Co. Spears Another Acquisition With Harpoon

Jan 09 2024

J&J Makes Its Biggest Bet Yet On Antibody-Drug Conjugates With Ambrx Buyout

Jan 08 2024

Related Companies

Johnson & Johnson

Merck & Co., Inc.

Ambrx Biopharma, Inc.

Harpoon Therapeutics

Immunocore, Ltd.

Vir Biotechnology, Inc.

Sanofi

Pfizer Inc.

AstraZeneca PLC

Eli Lilly and Company

Novo Nordisk A/S

Takeda Pharmaceutical Co. Ltd.

Regeneron Pharmaceuticals, Inc.

Additional Topics

Business Strategies Gene Therapy Growth Innovation Deals Market Access Pricing Debate Commercial Strategy BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window